TaiGen Biotechnology

About:

TaiGen is a pharmaceutical company discovering, developing and commercializing drugs to treat cancers, infectious diseases and diabetics.

Website: http://www.taigenbiotech.com.tw

Top Investors: MPM Capital, YFY Inc., National Development Fund of Taiwan Government, Shin Kong Life Insurance, China Development Industrial Bank (CDIB)

Description:

TaiGen Biotechnology Co. is a pharmaceutical company based in Taiwan. The company focuses on the discovery, development and commercialization of therapeutics to treat cancers, infectious diseases and diabetic complications (limb ischemia and retinopathy). TaiGen currently has operations in Taiwan, China, and the U.S.

Total Funding Amount:

$75M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Taipei, T'ai-pei, Taiwan

Founded Date:

2001-05-01

Contact Email:

service(AT)taigenbiotech.com.tw

Founders:

Ming Hsu

Number of Employees:

101-250

Last Funding Date:

2009-01-01

IPO Status:

Public

Industries:

© 2025 bioDAO.ai